Publications by authors named "Troy Melander"
Objectives: To estimate potential impacts of California Assembly Bill (AB) 1316: a requirement for universal screening and insurance coverage for child blood lead testing.
Methods: In April 2017 the California Health Benefits Review Program (Oakland, CA) analyzed AB 1316 for the California legislature, including a systematic review of lead screening effectiveness, commercial insurer surveys regarding screening coverage, and actuarial utilization and cost implication assessments.
Results: Universal screening requirements would increase child lead testing by 273%, raise affected populations' premiums by 0.